S 480 114th Congress Senate Health Congressional oversight Criminal justice information and records Drug trafficking and controlled substances Drug, alcohol, tobacco use Health information and medical records Health programs administration and funding Health technology, devices, supplies Licensing and registrations Medical research Prescription drugs State and local government operations

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

Introduced: February 12, 2015 Introduced by: Shaheen, Jeanne Democratic · New Hampshire See on congress.gov

Everywhere this bill has been 5 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Apr 27, 2016

Placed on Senate Legislative Calendar under General Orders. Calendar No. 440.

Apr 27, 2016

Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

Mar 16, 2016

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

Feb 12, 2015

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Feb 12, 2015

Introduced in Senate

Plain-English summary Congressional Research Service

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

(Sec. 3) This bill amends the Public Health Service Act to revise and extend through FY2021 the controlled substance monitoring program, including to:

allow grants to be used to maintain existing state controlled substance monitoring programs;
require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees;
require states to report on the interoperability of their programs with federal programs and health information technology systems and whether their programs provide automatic, up-to-date, or daily information about a patient upon request;
require states to provide HHS with aggregate data and other information to enable HHS to evaluate the success of state programs; and
expand the program to include any commonwealth or territory of the United States.

The Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

HHS is no longer required to give preference for grants related to drug abuse to states with controlled substance monitoring programs.

A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system.

What's happening now April 27, 2016

Placed on Senate Legislative Calendar under General Orders. Calendar No. 440.

Committees of jurisdiction 1